| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $190K | — | — |
| R&D Expense | $22.1M | +43.9% | +49.5% |
| SG&A Expense | $4.8M | -2.5% | +44.0% |
| Operating Income | -$26.7M | -31.7% | -47.4% |
| Net Income | -$25.7M | -31.8% | -49.2% |
| EPS (Basic) | -$0.26 | -18.2% | -13.0% |
| EPS (Diluted) | -$0.26 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.2M | -64.3% | -46.3% |
| Short-term Investments | $79.0M | — | — |
| Current Assets | $93.0M | +6.3% | +21.9% |
| Total Assets | $106.7M | +5.0% | +16.4% |
| Current Liabilities | $15.7M | +0.9% | +11.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$49.8M | — | — |
| Capital Expenditures | $46K | — | — |
| Investing Cash Flow | -$21.5M | — | — |
| Financing Cash Flow | $66.1M | — | — |
| Free Cash Flow | -$49.8M | — | — |
| -13.0% |
| $80.2M |
| +7.2% |
| +22.8% |